G. Cranswick

The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke

Peter Sandercock, Joanna Wardlaw, G Middleton, 1997, The Lancet.

Thigh-Length Versus Below-Knee Stockings for Deep Venous Thrombosis Prophylaxis After Stroke

J. Slattery, P. Sandercock, A. Fraser, 2010, Annals of Internal Medicine.

The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke

H. R. Taylor, R. Collins, A. Brownlie, 1997, The Lancet.

FOOD: a multicentre randomised trial evaluating feeding policies in patients admitted to hospital with a recent stroke.

M. Dennis, J. Forbes, S. Lewis, 2006, Health technology assessment.

Amiloride, fluoxetine or riluzole to reduce brain volume loss in secondary progressive multiple sclerosis: the MS-SMART four-arm RCT

Richard A. Parker, S. Ourselin, F. Barkhof, 2020, Efficacy and Mechanism Evaluation.

Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART): a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis

Richard A. Parker, S. Ourselin, F. Barkhof, 2018, BMJ Open.

Duration of External Neck Stabilisation (DENS) following odontoid fracture in older or frail adults: protocol for a randomised controlled trial of collar versus no collar

J. Norrie, S. Shenkin, M. Reed, 2022, BMJ Open.

Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial

S. Ourselin, F. Barkhof, D. MacManus, 2020, The Lancet Neurology.